Skip to main content

Health

More in Health

Regenerative MedicineTrade-off Analysis

Tooth Regrowth Drug Enters Phase 2 Human Trials, Promising End to Cavities and Implants

Regenerative Researchers 40%Clinical Dentists 40%Patient Advocates 20%

3 sources · 15d ago

Resistance TrainingGuideline Update

ACSM Issues First Major Resistance Training Guideline Update in 17 Years, Emphasizing Power and Consistency

Clinical Exercise Physiologists 40%Strength & Conditioning Coaches 30%Healthy Aging Advocates 30%

8 sources · 15d ago

ExplainerCKM Syndrome

Landmark Guideline from Four Major Societies Defines New 'Cardiovascular-Kidney-Metabolic Syndrome'

Guideline Authors 60%Primary Care Providers 25%Public Health Advocates 15%

5 sources · 15d ago

ExplainerPrecision Nutrition

Landmark PREDICT Study Finds Metabolic Response to Food Is Highly Personalized, Varies 10-Fold

Clinical Researchers 35%Precision Nutrition Advocates 35%Public Health Dietitians 29%

6 sources · 16d ago

ExplainerHormonal Health

Global Coalition Renames Polycystic Ovary Syndrome (PCOS) to PMOS, Signaling Fundamental Shift in Disease Definition

Endocrinologists & Metabolic Specialists 40%Reproductive Specialists 30%Patient Advocacy Groups 30%

5 sources · 16d ago

Obesity TherapeuticsExplainer

Phase 3 Data for 'Trillion-Dollar' Retatrutide Spurs FDA Warning Against Expanding Gray Market for Unapproved Drug

Clinical Researchers 40%Regulatory Authorities 40%Industry Observers 20%

7 sources · 16d ago

Vaccine PolicyExplainer

CDC Data Shows Record High Vaccine Exemptions for Kindergartners Amid Measles Resurgence

Public Health Advocates 40%Pediatric Clinicians 40%Parental Choice Advocates 20%

7 sources · 16d ago

Prostate CancerTreatment Explainer

FDA Approves Targeted Radionuclide Therapy for Earlier Use in Metastatic Prostate Cancer

Clinical Oncologists 44%Patient Advocates 31%Nuclear Medicine Specialists 25%

7 sources · 16d ago

Supplement RegulationPolicy Explainer

FDA Considers Major Rule Change to Allow Peptides and New Substances in Dietary Supplements

Supplement Industry Advocates 40%Consumer Safety Advocates 35%Medical & Peptide Researchers 25%

5 sources · 16d ago

ExplainerInsomnia Treatment

New AASM Guideline Endorses Combination Therapy for Chronic Insomnia, Reframing Role of Sleep Medications

Behavioral Sleep Specialists 40%Clinical Pragmatists 35%Patient Advocates 25%

3 sources · 16d ago

AnalysisCancer Research

FDA Approves Vepdegestrant, First-in-Class PROTAC Drug, Ushering in New Era of Targeted Cancer Therapy

Oncology Researchers 40%Clinical Practitioners 35%Patient Advocates 25%

4 sources · 16d ago

Menopause CarePolicy Reversal

FDA Removes Black Box Warnings on Menopausal Hormone Therapy, Reversing Two Decades of Policy

Menopause Specialists 45%Public Health Regulators 35%Oncology Researchers 20%

6 sources · 16d ago

Pediatric NeurologyTreatment Trade-Offs

FDA Grants Priority Review to Ecopipam, First Novel-Mechanism Drug for Pediatric Tourette Syndrome in 50 Years

Ecopipam Investigators 50%Clinical Neurologists 30%Pharmacy Analysts 20%

6 sources · 16d ago

Alzheimer's DiseaseClinical Trial

New Tau-Targeting Drug Halves Cognitive Decline in Alzheimer's Phase 2 Trial

Clinical Researchers 40%Alzheimer's Advocacy Groups 30%Cautious Analysts 30%

7 sources · 16d ago

Research BriefBipolar Disorder

Landmark Review Identifies Best Drug and Non-Drug Treatments for Bipolar Disorder Across All Mood Phases

Clinical Researchers 40%Patient Advocates 35%Pediatric Specialists 25%

5 sources · 16d ago

ExplainerPsychedelic Medicine

FDA Issues Final Guidance, Formalizing Regulatory Pathway for Psychedelic Drug Therapies

Regulatory Authorities 40%Clinical Researchers 35%Psychedelic Therapy Advocates 25%

6 sources · 16d ago

ExplainerGLP-1 Research

Ozempic Works by Unexpectedly Activating Brain's Hunger Neurons to Sustain Fat Loss

Metabolic Researchers 40%Science Communicators 30%Clinical Analysts 30%

4 sources · 16d ago

Vaccine MandatesPolicy Decision

Supreme Court Weighs State Power to Ban Religious Vaccine Exemptions

Public Health & Medical Consensus 40%Constitutional & Legal Historians 35%Federal Policy Watchers 25%

6 sources · 15d ago

ExplainerBlood Safety

Lancet Review Suggests Alzheimer's Proteins May Be Transmitted Via Blood Transfusions

Clinical Investigators 45%Patient Safety Advocates 45%Editorial Synthesis 10%

3 sources · 17d ago